Erythrina sigmoidea
Erythrina sigmoidea · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Erythrina sigmoidea is a botanical species that has garnered scientific interest due to its diverse pharmacological activities, specifically its antioxidant and antiplasmodial properties. Researchers have identified key chemical constituents within the plant, including Abyssinone IV, Corylin, Eriotrichin B, and Erybraedin A. Studies focusing on the root and stem suggest significant therapeutic potential against serious conditions such as cancer and malaria. Specifically, investigations utilize preparations like the root bark, stem bark extracts, and methylene chloride extracts to isolate these bioactive compounds. Through these targeted preparations, the plant offers a promising pathway for developing new medicinal treatments.
- Synonyms
- Erythrina Eriotricha · Erythrina Dybowskii · 1 more
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Root · Stem
Classification
Synonyms
Erythrina sigmoidea is a plant species that has been subject to various taxonomic reclassifications over time. In botanical literature, it is frequently identified through several distinct synonyms. For instance, the species is sometimes referred to as Erythrina dybowskii in specific contexts. Other scientific names associated with this plant include Erythrina eriotricha and Erythrina sudanica. Understanding these overlapping nomenclatures is essential for researchers tracking the plant's true identity.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Erythrina sigmoidea is a distinctive biological specimen belonging to the kingdom Plantae. Within this vast kingdom, the plant is classified under the class Equisetopsida. It further resides in the order Fabales, showcasing its specific evolutionary lineage. The species is a member of the family Fabaceae, which connects it to a diverse group of flowering plants. Ultimately, it is defined by its taxonomic placement within the genus Erythrina.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Erythrina |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Erythrina sigmoidea is a plant species with a diverse distribution spanning across various regions of the African continent. Within Northeast Tropical Africa, its presence is noted in countries such as Chad and the borderlands of Sudan and South Sudan. The species also extends its range into West Tropical Africa, where it can be found in several distinct nations. Specifically, populations have been documented in Benin, Burkina Faso, and Guinea. This broad geographical spread highlights the adaptability of the species across different African landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Erythrina sigmoidea is a self-supporting plant that takes the form of a sturdy tree. This species typically reaches a significant stature in its natural habitat. Most specimens maintain a height ranging from a minimum of 3.05 meters up to a maximum of approximately 6.10 meters. Such dimensions allow it to stand prominently within its ecological community.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Erythrina sigmoidea has demonstrated significant biological potential through its dual antioxidant and antiplasmodial activities. Research into stem bark extracts has shown that this plant is highly effective at scavenging free radicals, contributing to its strong antioxidant profile. Furthermore, the plant exhibits potent antiplasmodial properties, particularly when studied in combination with other medicinal species to combat malaria parasites. Studies specifically highlight its ability to target essential enzymes like PfDHFR, which is critical for managing drug-resistant strains of Plasmodium falciparum. These combined therapeutic characteristics suggest that Erythrina sigmoidea holds great promise for future pharmaceutical development.
Compounds
Erythrina sigmoidea is a plant species known to harbor a diverse array of chemically significant compounds. Detailed phytochemical analyses have revealed that its stem and bark contain the flavanone abyssinone IV. Furthermore, investigations into the plant's roots have identified the presence of the isoflavone corylin. While some related species share specific metabolites, research highlights that this species is a rich source of unique bioactive constituents. Ultimately, understanding these internal chemical relationships provides essential insight into the complex secondary metabolism of the Erythrina genus.
Conditions
Erythrina sigmoidea demonstrates significant medicinal potential through its ability to treat cancer, particularly through its cytotoxic effects on various cell lines. Specifically, extracts from the bark of this plant have shown effectiveness in treating colon carcinoma HCT116 (p53(+/+)) cells. Research also highlights its capacity to treat leukemia CCRF-CEM cells, including the resistant P-glycoprotein over-expressing subline CEM/ADR5000. Beyond its anticancer properties, the plant is utilized for its ability to treat malaria, often in combination with other species. These diverse therapeutic actions position Erythrina sigmoidea as a valuable candidate for future phytomedicine development.
Preparations
Erythrina sigmoidea is prepared as root bark to facilitate the isolation and characterization of specific compounds like sigmoidin J and K. This medicinal plant is also prepared as a methylene chloride extract for the purpose of chemical study and fractionation. Furthermore, Erythrina sigmoidea is prepared as stem bark extracts to evaluate its potential antimalarial and antioxidant activities. These different preparation methods allow researchers to investigate various phytochemical components and biological properties. Through these specific preparations, the plant's therapeutic potential in managing malaria can be scientifically assessed.
Parts used
Erythrina sigmoidea is a medicinal plant that yields various bioactive compounds from different anatomical structures. Research indicates that the root bark of this species serves as a source for several novel prenylated isoflavonoids, such as sigmoidin J, K, and I. Furthermore, the roots are utilized to isolate specific isoflavones and pterocarpans that contribute to its chemical profile. Beyond the roots, the stem and bark of the plant are also significant, providing access to unique substances like the new prenylated flavanone, sigmoidin F. These diverse plant parts are essential for studying the species' potential in treating conditions such as malaria.